Prescient Therapeutics Limited (AU:PTX) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Prescient Therapeutics Limited’s 2024 Annual General Meeting saw the approval of key resolutions, including the election of Dr. Gavin Shepherd and Dr. James Campbell as directors, and the issuance of options to Dr. Shepherd. However, the proposal for a 10% placement facility was not carried, showcasing a significant shareholder dissent.
For further insights into AU:PTX stock, check out TipRanks’ Stock Analysis page.